Amgen Inc. Repayments of Other Debt
Amgen Inc. (AMGN) reported Repayments of Other Debt of $4.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2014-02-24
- Amgen Inc. repayments of other debt for fiscal 2013 was $4.00M.
| Period end | Repayments of Other Debt 6 month | Repayments of Other Debt 12 month |
|---|---|---|
| 2013-12-31 | $4.00M 10-K · filed 2014-02-24 | |
| 2009-06-30 | $0.00 10-Q · filed 2009-08-10 | |
| 2008-06-30 | $1.00B 10-Q · filed 2009-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |